Compare Humana Inc (HUM) vs iShares 10 20 Year Treasury Bond ETF (TLH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs iShares 10 20 Year Treasury Bond ETF — how do they compare? Humana Inc trades at $439.56 (market cap $47.61B), while iShares 10 20 Year Treasury Bond ETF trades at $92 (market cap $10.78B). The key difference: Humana Inc is far larger — about 4.4× iShares 10 20 Year Treasury Bond ETF's market cap, and Humana Inc pays a 0.89% dividend while iShares 10 20 Year Treasury Bond ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and iShares 10 20 Year Treasury Bond ETF for 62 Days on average.
| HUM | TLH | |
|---|---|---|
Market Cap | $47.61B | $10.78B |
Volume | 1,827,332 | 4,408,295 |
Sector | Health | Fixed Income |
52-Week High | $409.85 | $105.36 |
52-Week Low | $163.67 | $91.34 |
Typical Hold Time | 53 Days | 62 Days |
Enterprise Value | $54.97B | — |
Dividend Yield | 0.89% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $387.12, down 4.24% today, but maintains a bullish technical outlook with strong institutional support. The stock shows mixed fundamentals with revenue growth to $129.66B in 2025 but declining profit margins at 0.88%. Recent analyst upgrades, including Barclays' $515 target on September 25, 2026, highlight optimism despite ongoing Medicare Advantage plan adjustments affecting member transitions.
Investment outlook remains cautiously optimistic with a consensus price target of $432.63 offering 12% upside. Risks include margin compression, regulatory scrutiny from Medicare billing practices, and competitive pressures in managed care. The company's strong cash position of $20.44B and consistent dividend payments provide stability amid enrollment volatility.
TLH (iShares 10-20 Year Treasury Bond ETF) is trading at $91.45, down 0.12% with a bearish technical signal. The ETF shows unusually high trading volume and faces pressure from rising Treasury yields, which reached multi-decade highs recently. Dividend distributions continue with recent payments of $0.36-$0.38 per share, but key valuation ratios remain unavailable for analysis.
The outlook remains challenging as bond markets face persistent yield pressures from inflation concerns and Fed policy uncertainty. Investment opportunity exists for yield-seeking investors, but risks include continued bond market volatility and potential further yield increases that could pressure ETF prices lower.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About iShares 10 20 Year Treasury Bond ETF
TLH tracks the ICE U.S. Treasury 10-20 Year Bond Index, offering targeted exposure to intermediate-to-long term government debt. It serves as a middle ground between the 7-10 year (IEF) and 20+ year (TLT) ETFs, balancing yield and duration risk.
Read more on TLH →
